Nektar Therapeutics (NKTR) Other Non Operating Income (2010 - 2026)

Nektar Therapeutics' Other Non Operating Income history runs 17 years deep, the most recent figure standing at -$336000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 226.32% year-over-year to -$336000.0; the TTM figure through Mar 2026 stood at -$241000.0 (down 864.0% YoY), while the FY2025 annual figure was $361000.0, up 192.56% from the prior year.
• Other Non Operating Income was -$336000.0 for Q1 2026 at Nektar Therapeutics, down from -$44000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $33.4 million in Q1 2022 to a low of -$6.3 million in Q4 2023.
• Historically, Other Non Operating Income has averaged $1.5 million across 5 years, with a median of -$120000.0 in 2024.
• The sharpest annual moves came in 2022 and 2026: Other Non Operating Income surged 2267.35% in 2022, then sank 226.32% in 2026.
• A 5-year view of Other Non Operating Income shows it stood at -$3.7 million in 2022, then sank by 73.56% to -$6.3 million in 2023, then soared by 97.87% to -$135000.0 in 2024, then surged by 67.41% to -$44000.0 in 2025, then plunged by 663.64% to -$336000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$336000.0 (Q1 2026), -$44000.0 (Q4 2025), and -$121000.0 (Q3 2025), per Business Quant data.